NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-62.7%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-62.7%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 7.04% |
| 2024 | -12.74% |
| 2023 | -1452.37% |
| 2022 | 135.36% |
| 2021 | -301.37% |
| 2020 | 0.00% |